N/A
N=452
Promoting the Universal Medication Schedule Via Mobile and EHR Technologies
Type 2 Diabetes
Bottom Line
View on ClinicalTrials.gov: NCT02248857 ↗Enrolled (actual)
452
Serious AEs
0.0%
Results posted
Mar 2019
Primary outcome: Primary: Prescription Understanding — 0.81; 0.82; 0.78 Probability
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- UMS Strategy (Other); SMS Texting Reminders (Other)
- Age
- Adult, Older Adult · 30+ yrs
- Sex
- All
- Sponsor
- Northwestern University
- Primary completion
- Dec 2016
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Prescription Understanding |
0.81; 0.82; 0.78 | — |
| SECONDARY Medication Knowledge |
0.21; 0.28; 0.26 | — |
| SECONDARY Medication Adherence: Pill Count |
0.41; 0.31; 0.34 | — |
| SECONDARY Medication Adherence: PMAQ |
0.71; 0.72; 0.77 | — |
| SECONDARY Medication Adherence: Pharmacy Records |
0.49; 0.59; 0.55 | — |
Summary
The purpose of this study test the effectiveness of the Universal Medication Schedule (UMS), which was designed as a strategy to standardize and simplify medication instructions to support safe and effective prescription drug use among diabetic.
Eligibility Criteria
Inclusion Criteria
- diagnosis of type II diabetes
- age 30 or older
- taking 3 or more prescription medications for chronic conditions
- English or Spanish speaking
Exclusion Criteria
- self-reported severe, uncorrectable vision
- hearing impairment
- cognitive impairment
- not responsible for administering his/her own medications
- not able to receive text messages on their cell phone
Data sourced from ClinicalTrials.gov (NCT02248857). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.